PaySign Inc. Conference Call Summary Company Overview - **Company Name**: PaySign Inc. (Ticker: PAYS) - **Industry**: Payment services, primarily in healthcare - **Headquarters**: Southern Nevada, near Las Vegas - **Incorporation Year**: 1995 - **Public Listing**: Went public through a reverse merger in 2018 Core Business Segments - **Healthcare Payments**: Predominantly provides payment services to the healthcare industry, including patient affordability programs and plasma donor payments [5][9] - **Patient Affordability Programs**: Helps patients cover copays for expensive medications, with a focus on reducing abandonment rates for prescriptions [9][10] - **Plasma Industry**: Engaged in electronic payments for plasma donation centers, holding a 40% market share in the U.S. [8][11] Financial Performance - **Revenue**: - 2024 projected revenue: $58.4 million - 2023 revenue: $87 million from plasma business and $12.7 million from patient affordability [11][16] - Patient affordability business expected to grow at least 135% in 2024 [11] - **Adjusted EBITDA**: $13 million for the trailing twelve months, with margins improving [16][34] - **Cash Position**: $111 million in cash, with zero debt [15][34] - **Gross Margins**: Increased to 62.9% from 53% year-over-year [14] Market Dynamics - **Plasma Market**: - U.S. provides over 75% of the world's plasma, with a normal growth rate of about 5% annually [8][26] - Anticipated decline of 8-10% in plasma business revenue due to operational adjustments post-COVID [26] - **Patient Affordability Market**: - Total Addressable Market (TAM) estimated at over $500 million, indicating significant growth potential [29] Strategic Initiatives - **Acquisition of Gamma Innovation**: - Acquired for $16 million, aimed at enhancing software capabilities in the plasma industry [28][30] - **Dynamic Business Rules Technology**: - Proprietary technology that saved customers over $100 million in claims in 2024, expected to double in 2025 [22] Leadership and Expertise - **Senior Leadership**: Comprised of individuals with extensive backgrounds in banking, payments, and healthcare, enhancing domain expertise [13][39] - **Analyst Coverage**: Covered by five firms, all with buy or equivalent ratings, target prices ranging from $6 to $8 [35] Additional Insights - **Customer Engagement**: The company emphasizes direct partnerships with pharmaceutical companies, enhancing payment capabilities and transparency [42][44] - **Operational Efficiency**: The call center operates at breakeven, indicating effective cost management [17] - **Regulatory Environment**: The company operates primarily in the U.S. market, with limited applicability of its services outside due to different healthcare systems [37] Conclusion PaySign Inc. is positioned for growth in the healthcare payment sector, with strong financials, innovative technology, and a strategic focus on expanding its market share in both the plasma and patient affordability segments. The leadership team's expertise and recent acquisitions further bolster its competitive advantage in a rapidly evolving industry.

Paysign (PAYS) Q4 2024 Earnings Call March 25, 2025 11:27 PM ET Company Participants Mark Newcomer - Co-Founder, President, CEO & ChairmanJeffery Baker - CFO & TreasurerGary Prestopino - Managing DirectorMatthew Turner - President of Patient AffordabilityPeter Heckmann - MD - Equity ResearchMatthew Lanford - Chief Payments Officer Conference Call Participants Jacob Stephan - Senior Research Analyst Operator Good afternoon. My name is Kevin, and I'll be your conference operator today. At this time, I'd like ...

Paysign, Inc. (NASDAQ:PAYS) Q4 2024 Earnings Conference Call March 25, 2025 5:00 PM ET Company Participants Mark Newcomer - President and CEO Jeff Baker - CFO Matt Turner - President, Patient Affordability Matt Lanford - CPO Conference Call Participants Jacob Stephan - Lake Street Capital Markets Gary Prestopino - Barrington Research Peter Heckmann - D.A. Davidson Operator Good afternoon. My name is Kevin and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Paysign, ...